Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab

BACKGROUND: The peritoneum is one of the most frequent sites of recurrent gastric carcinoma after curative treatment, despite the administration of pre- and/or postoperative systemic chemotherapy. Indeed, the prognosis of peritoneal carcinomatosis from gastric carcinoma continues to be poor, with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goéré, Diane, Gras-Chaput, Nathalie, Aupérin, Anne, Flament, Caroline, Mariette, Christophe, Glehen, Olivier, Zitvogel, Laurence, Elias, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973895/
https://www.ncbi.nlm.nih.gov/pubmed/24589307
http://dx.doi.org/10.1186/1471-2407-14-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973895/
https://www.ncbi.nlm.nih.gov/pubmed/24589307
http://dx.doi.org/10.1186/1471-2407-14-148

Ejemplares similares